$1.06▼ 0.02 (1.86%)
Real-time prices · US MarketsClean balance sheet with low leverage (0.1× debt-to-equity).
valuation metrics above sector average.
Quality
7.8
Health
8.1
Growth
6
Valuation
5
Sentiment
7.4
Analyst Target
—
Price Chart
Latest News
Fundamentals
Trailing P/E
2.5×
price-to-earnings
Forward P/E
48.0×
next 12 months est.
Market Cap
$152M
market capitalization
Div Yield
—
dividend yield
Profit Margin
28.0%
net profit margin
Gross Margin
36.5%
revenue minus COGS
ROE
17.6%
return on equity
Beta
1.91
vs S&P 500
52-Week Range
$1 — $2
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
What do analysts say about Organigram Global Inc. right now?
Organigram Global Inc.'s Q·Score is 6.9/10 (Neutral), reflecting its current fundamentals, analyst data, and valuation metrics. Clean balance sheet with low leverage (0.1× debt-to-equity). Key area to monitor: valuation metrics above sector average. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
Is OGI overvalued or undervalued?
Organigram Global Inc. (OGI) scores in line with sector averages on valuation metrics. Its forward P/E ratio stands at 48.0×.
What is Organigram Global Inc.'s profit margin?
Organigram Global Inc. has a net profit margin of 28.0%, which is considered high and reflects strong pricing power. Its gross margin stands at 36.5%, reflecting a more cost-intensive business model.
Is Organigram Global Inc.'s revenue growing?
Organigram Global Inc. is reporting strong year-over-year growth of 49.4%.
How much debt does Organigram Global Inc. have?
Organigram Global Inc. has a debt-to-equity ratio of 0.06×, reflecting a very low debt-to-equity ratio, signalling a conservatively financed balance sheet. Its current ratio is 2.61×, indicating comfortable short-term liquidity.